SCM
PRLD icon

Sio Capital Management’s Prelude Therapeutics PRLD Stock Holding History

Sio Capital Management’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-320,394
Closed -$1.22M – 51
2024
Q2 		$1.22M Hold
320,394
– – 0.33% 36
2024
Q1 		$1.52M Hold
320,394
– – 0.45% 40
2023
Q4 		$1.37M Sell
320,394
-29,606
-8% -$90.1K 0.31% 28
2023
Q3 		$1.08M Buy
+350,000
New +$1.31M 0.33% 36

Other funds holding PRLD

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sio Capital Management's PRLD Position: Q3 2024 in Review

Sio Capital Management sold out of Prelude Therapeutics (PRLD) in Q3 2024, closing a stake of 320,394 shares — an estimated $1.22M sold.

Sio Capital Management first reported a position in PRLD in Q3 2023 and held it in 4 quarters. The position peaked at $1.52M in Q1 2024. 70 funds tracked by Wall St. Rank hold PRLD as of Q3 2024.

  • Sio Capital Management reported no remaining Prelude Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Sio Capital Management sold 320,394 Prelude Therapeutics shares in Q3 2024, an estimated $1.22M.
  • Sio Capital Management first reported a position in Prelude Therapeutics in Q3 2023 and held it in 4 quarters.
  • Sio Capital Management's Prelude Therapeutics position peaked at $1.52M in Q1 2024.
  • 70 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2024.

Based on Sio Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.